Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

myoclonic encephalopathy in non-progressive disorder - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

myoclonic encephalopathy in non-progressive disorder

MONDO:0100026

Overview

This group of epilepsies are typically is characterized by onset of seizures from day 1 of life to 5 years (peak 12 months). Both sexes are affected, however the male to female ratio is 1:2. Antecedent (including birth) history, head size, neurological and developmental findings reflect the underlying cause (if known). Myoclonic status epilepticus is often the initial presenting seizure type, however other initial seizure types may also occur. Prognosis is unfavorable with severe neurological and developmental impairments typically seen.

ResearchLimited published research (4 articles)

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for myoclonic encephalopathy in non-progressive disorder.

4 publications have been identified in PubMed for myoclonic encephalopathy in non-progressive disorder. Research spans Review / Meta-Analysis (50%), Case Report / Case Series (25%), and Epidemiology / Natural History (25%).

Recent Publications

Magro G (2025). [PMID: 40869578](https://pubmed.ncbi.nlm.nih.gov/40869578/). *Journal of clinical medicine*. [Review / Meta-Analysis]
Kapoor D (2025). [PMID: 40794016](https://pubmed.ncbi.nlm.nih.gov/40794016/). *Epileptic disorders : international epilepsy journal with videotape*. [Review / Meta-Analysis]
Brulé S (2025). [PMID: 40152936](https://pubmed.ncbi.nlm.nih.gov/40152936/). *Epilepsia*. [Epidemiology / Natural History]
Hojo M (2024). [PMID: 39627236](https://pubmed.ncbi.nlm.nih.gov/39627236/). *Human genome variation*. [Case Report / Case Series]

Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 1:16 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

myoclonic encephalopathy in non-progressive disorder

Overview

Research Landscape

Recent Publications

Medical References

Related Diseases

Questions for Your Care Team

Questions for Your Care Team